The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
SLC19A1 is an importer of the immunotransmitter cGAMP.
Open accessPublished version of a preprint
Abstract
2'3'-cyclic-GMP-AMP (cGAMP) is a second messenger that activates the antiviral stimulator of interferon genes (STING) pathway. We recently identified a novel role for cGAMP as a soluble, extracellular immunotransmitter that is produced and secreted by cancer cells. Secreted cGAMP is then sensed by host cells, eliciting an antitumoral immune response. Due to the antitumoral effects of cGAMP, other CDN-based STING agonists are currently under investigation in clinical trials for metastatic solid tumors. However, it is unknown how cGAMP and other CDNs cross the cell membrane to activate intracellular STING. Using a genome-wide CRISPR screen, we identified SLC19A1 as the first known importer of cGAMP and other CDNs, including the investigational new drug 2'3'-bisphosphosphothioate-cyclic-di-AMP (2'3'-CDA S). These discoveries will provide insight into cGAMP's role as an immunotransmitter and aid in the development of more targeted CDN-based cancer therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Interestingly, cGAMP is also secreted from cancer cells via SLC19A1, which induces activation of the STING pathway in recipient cells.78, 79”
From Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer (2020) · cites this paper as [78]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“Using a genome wide CRISPR interference screen, SLC19A1, was identified as the first known major importer of cGAMP, which is taken up by host cells to activate intracellular STING pathway to elicit an antitumor immune response.”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Ritchie et al., 2019
In the citing paper
“Recently, a novel role of cGAMP as a soluble extracellular immunotransmitter produced and secreted by malignant cells has been identified.”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Ritchie et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Sun, L., Wu, J., Du, F., Chen, X., & Chen, Z. J. (2013) · Science · doi:10.1126/science.1232458 · Cited by 4,996
Regulation of Adaptive Immunity by the Innate Immune System
Iwasaki, A., & Medzhitov, R. M. (2010) · Science · doi:10.1126/science.1183021 · Cited by 2,220
Deng, L., Liang, H., Xu, M., Yang, X., Burnette, B., Arina, A., Li, X.-D., Mauceri, H., Beckett, M., Darga, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.019 · Cited by 2,182
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Woo, S.-R., Fuertes, M. B., Corrales, L., Spranger, S., Furdyna, M. J., Leung, M. Y. K., Duggan, R., Wang, Y., Barber, G. N., Fitzgerald, K. A., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.017 · Cited by 1,917
cGAS surveillance of micronuclei links genome instability to innate immunity
Mackenzie, K. J., Carroll, P., Martin, C.-A., Murina, O., Fluteau, A., Simpson, D. J., Olova, N., Sutcliffe, H., Rainger, J. K., Leitch, A., et al. (2017) · Nature · doi:10.1038/nature23449 · Cited by 1,752
Chromosomal instability drives metastasis through a cytosolic DNA response
Bakhoum, S. F., Ngo, B., Laughney, A. M., Cavallo, J.-A., Murphy, C. J., Ly, P., Shah, P., Sriram, R. K., Watkins, T. B. K., Taunk, N. K., et al. (2018) · Nature · doi:10.1038/nature25432 · Cited by 1,593
STING is a direct innate immune sensor of cyclic di-GMP
Burdette, D. L., Monroe, K. M., Sotelo-Troha, K., Iwig, J. S., Eckert, B., Hyodo, M., Hayakawa, Y., & Vance, R. E. (2011) · Nature · doi:10.1038/nature10429 · Cited by 1,570
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 335
Myeloid dysregulation and therapeutic intervention in COVID-19
Gu, R., Mao, T., Qiao, L., Su, T. T., & Wang, J. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101524 · Cited by 14
Alshebremi, M., Tomchuck, S. L., Myers, J. T., Kingsley, D. T., Eid, S., Abiff, M., Bonner, M., Saab, S. T., Choi, S. H., & Huang, A. Y.-C. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006608 · Cited by 14
Yin, M., Kuang, W., Wang, Q., Wang, X., Yuan, C., Lin, Z., Zhang, H., Dèng, F., Jiang, H., Gong, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34761-0 · Cited by 14
How Cryo-EM Has Expanded Our Understanding of Membrane Transporters
Baril, S. A., Gose, T., & Schuetz, J. D. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.001004 · Cited by 14
Hou, Y., Lu, H., Li, J., Guan, Z., Zhang, J., Zhang, W., Yin, C., Sun, L., Zhang, Y., & Jiang, H. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.08.006 · Cited by 14
Yang, L., Tan, P., Sun, H., Zeng, Z., & Pan, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.874731 · Cited by 14
Precision targeting of STING: Challenges, innovations, and clinical outlook for cancer therapy
Shi, J., Zhang, Y., Zhao, N., Seki, E., Ma, L., Kocic, G. M., Li, X., Terzić, J., & Zheng, T. (2025) · The Innovation · doi:10.1016/j.xinn.2025.101074 · Cited by 16
The cGAS-STING pathway in cancer: friend or foe
Li, Q., Song, Q., Ma, L., Kang, K., Zhu, X., Li, Y., Lin, X., Lu, X., Zeng, Z., Li, G., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08607-2 · Cited by 15
He, X., Sun, Y., Lu, J., Naz, F., Ma, S., & Liu, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1117760 · Cited by 14
Phenotypic plasticity of melanocytes derived from human adult skin
Vidács, D. L., Veréb, Z., Bozó, R., Flink, L. B., Polyánka, H., Németh, I. B., Póliska, S., Papp, B. T., Manczinger, M., Gáspár, R., et al. (2021) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13012 · Cited by 13
Wang, Z., Hou, Y., Liu, P., Wu, R., Yang, J., Fan, S., Peng, Z., Han, X., Su, B., & Zhang, C. (2025) · Immunity · doi:10.1016/j.immuni.2025.10.007 · Cited by 13
Li, W., Yuan, P., Liu, W., Xiao, L., Xu, C., Mo, Q., Xu, S., He, Y., Jiang, D., & Wang, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843369 · Cited by 12
Phase Separation in cGAS‐STING Signaling: Cytosolic DNA Sensing and Regulatory Functions
Liu, C. X., Yang, J., Zheng, J., Fu, J., Wang, W., Duan, L., Qian, X. H., & Yang, Y. Y. (2023) · ChemBioChem · doi:10.1002/cbic.202300147 · Cited by 13
Microparticle and nanoparticle-based influenza vaccines
Ontiveros-Padilla, L. A., Bachelder, E. M., & Ainslie, K. M. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.031 · Cited by 11
Zhan, M., Sun, Y., Zhou, F., Wang, H., Chen, Z., Yan, L., & Li, X. (2022) · Xenobiotica · doi:10.1080/00498254.2022.2069060 · Cited by 11
Waanders, L., van der Donk, L. E. H., Ates, L. S., Maaskant, J. J., van Hamme, J. L., Eldering, E., van Bruggen, J. A. C., Rietveld, J. M., Bitter, W., Geijtenbeek, T. B. H., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005839 · Cited by 10
Deng, Y., Hahn, Q., Yu, L., Zhu, Z., Boyer, J. A., Wang, J., Kong, D., Carey, L. M., Hepperla, A. J., Simon, J. M., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado7024 · Cited by 10
Propagation of neuronal micronuclei regulates microglial characteristics
Yano, S., Asami, N., Kishi, Y., Takeda, I., Kubotani, H., Hattori, Y., Kitazawa, A., Hayashi, K., Kubo, K., Saeki, M., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-024-01863-5 · Cited by 15
DNA sensing of dendritic cells in cancer immunotherapy
Qian, W. P., Ye, J., & Xia, S. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1391046 · Cited by 10
ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathwayPreprint
Wang, S., Böhnert, V., Joseph, A. J., Sudaryo, V., Swinderman, J. T., Yu, F. B., Lyu, X., Skariah, G. M., Subramanyam, V., Gilbert, L. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.01.543353 · Cited by 10
Self-citationMardjuki, R. E., Wang, S., Carozza, J. A., Abhiraman, G. C., Lyu, X., & Li, L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.12.575449 · Cited by 11
Self-citationBranco, A. C. C. C., Rogers, L. M., & Aronoff, D. M. (2024) · Biomedicine Hub · doi:10.1159/000536186 · Cited by 11
Cytosolic delivery of innate immune agonists
Bharadwaj, R., Jaiswal, S., & Silverman, N. S. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.10.007 · Cited by 10
Hao, F. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02826-7 · Cited by 10
Lahey, L. J., Wen, X., Mardjuki, R. E., Böhnert, V., Hess, G. T., Ritchie, C., Carozza, J. A., Maduke, M. C., Bassik, M. C., & Li, L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.13.948273 · Cited by 9
Self-citationBöhnert, V., Gale, E. C., Lahey, L., Yan, J., Powell, A. E., Ou, B. S., Carozza, J., Li, L.-Y., & Appel, E. (2021) · bioRxiv · doi:10.1101/2021.07.03.451025 · Cited by 5
Self-citationRui, Y., Shen, S., Wang, Y., Cheng, L., Chen, S., Hu, Y., Cai, Y., Wei, W., Su, J., & Yu, X. (2025) · Science Signaling · doi:10.1126/scisignal.add6593 · Cited by 8
Molecular basis of SLC19A1-mediated folate and cyclic dinucleotide transport
Zhang, Q., Zhang, X., Liu, K., Zhu, Y., Nie, X., Ma, J., Sun, P., Li, Z., Gao, Y., Liu, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58378-1 · Cited by 9
Wang, S., Johnson, R. M., Carozza, J. A., Fernández, D., Scicinski, J. J., Verity, N. A., Mardjuki, R. E., Cao, X., Guo, Y., Papkoff, J. S., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102336 · Cited by 12
Self-citationLiu, H., Hu, C., Liu, H., Gong, Z., Jiang, S., Xie, J., Li, Y., Liu, C., Wang, Y., Zou, C., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03815-1 · Cited by 9
Jindal, D., Chopra, V., Garg, K., & Sharma, S. (2026) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2026.05.001 · Cited by 9
Cancer-cell-derived cGAMP limits the activity of tumor-associated CD8+ T cells
Herbst, M., Köksal, H., Brunn, S., Zanetti, D., Domocos, I., Stefani, V. D., Gatti, M., Vivalda, F., Pereira, P., Nater, M., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115510 · Cited by 7
Ramos, A. E., Bizri, N. A., Novak, E. A., Mollen, K. P., & Khan, S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1409683 · Cited by 7
York, A., Everhart, A. L., Vitek, M. P., Gottschalk, W. K., & Colton, C. A. (2021) · ASN NEURO · doi:10.1177/17590914211019443 · Cited by 6
Choi, J. (2022) · Bulletin of the Korean Chemical Society · doi:10.1002/bkcs.12646 · Cited by 7
CD38 restrains the activity of extracellular cGAMP in a model of multiple myeloma
Cuollo, L., Cristofano, S. D., Sandomenico, A., Iaccarino, E., Oliver, A., Zingoni, A., Cippitelli, M., Fionda, C., Petillo, S., Kosta, A., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109814 · Cited by 7
Szemere, Z. K., & Murphy, E. A. (2024) · Antiviral Research · doi:10.1016/j.antiviral.2024.105989 · Cited by 6
Emerging molecular mechanisms of cGAS-STING activation and regulation
Liu, Y., Ma, K., & Jiang, Z. (2026) · Molecular Immunology · doi:10.1016/j.molimm.2026.02.008 · Cited by 6
Lu, Y. D., You, L., Li, L., Kilgore, J. A., Liu, S., Wang, X., Dai, Y., Wei, Q., Shi, H., Han, L., et al. (2023) · ACS Central Science · doi:10.1021/acscentsci.3c01122 · Cited by 6
Self-citationAu naturale: use of biologically derived cyclic di-nucleotides for cancer immunotherapy
Waters, C. M. (2021) · Open Biology · doi:10.1098/rsob.210277 · Cited by 6
Folate transporter offers clues for anticancer drugs
Matherly, L. H., & Hou, Z. (2022) · Nature · doi:10.1038/d41586-022-03767-5 · Cited by 6
Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment
Mengqiu, W. A. N. G., Xu, P., & Wu, Q. (2024) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2023-0482 · Cited by 5
Böhnert, V., Gale, E. C., Lahey, L. J., Yan, J., Powell, A. E., Ou, B. S., Carozza, J. A., Li, L., & Appel, E. A. (2024) · Advanced NanoBiomed Research · doi:10.1002/anbr.202400077 · Cited by 14
Self-citationProtocol for detection of cGAMP-induced STING oligomerization in cultured cells
Liu, L., & Manley, J. L. (2025) · STAR Protocols · doi:10.1016/j.xpro.2025.103709 · Cited by 5
Pan, Y., Liu, Z., & Wu, C. (2025) · Biomedicines · doi:10.3390/biomedicines13030571 · Cited by 5
Improving Cancer Immunotherapy with CRISPR‐Based Technology
Li, Z., & Teng, F. (2020) · Advanced Biosystems · doi:10.1002/adbi.201900253 · Cited by 6
Systematic discovery of pathogen effector functions across human pathogens and pathways
Pachano, T., Leng, H., Dugied, G., Tribble, T., Loubière, V., Lee, Y., Rauh, F., Manon, V., Yuan, K., Nurtanto, J., et al. (2026) · Cell · doi:10.1016/j.cell.2026.06.017 · Cited by 5
Chen, D., Liu, A., Wang, Z., Wang, C., Hu, J., Wang, D., & Yao, D. (2026) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2026.217976 · Cited by 4
STING agonists as next-generation vaccine adjuvants: mechanisms, opportunities, and challenges
Temizoz, B., & Ishii, K. J. (2026) · Current Opinion in Virology · doi:10.1016/j.coviro.2026.101543 · Cited by 4
Yeboah, S. K., Meher, S., Harper, H. A., McMahan, C. J., Elzey, B. D., & Sintim, H. O. (2025) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.5c00070 · Cited by 4
Priya, R., Ye, M., Raghunandanan, S., Liu, Q., Li, W., Yu, Q., Lou, Y., Sintim, H. O., & Yang, X. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf133 · Cited by 4
Lu, Y., Li, Z., Xu, H., Zeng, Q., Zhu, X., Chen, K., Zheng, W., Liu, S., Guan, W., & Wu, J. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114284 · Cited by 4
Targeting VCP enhances colorectal cancer therapy through STING stabilization
Zhu, H., Ge, F., Dai, J., Yang, S., Yuan, T., Zheng, C., Dong, X., Hu, R., Zhou, T., He, Q., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012652 · Cited by 7
Mechanism of DNA degradation by CBASS Cap5 endonuclease immune effector
Rechkoblit, O., Sciaky, D., Ni, M., Li, Y., Kottur, J., Fang, G., & Aggarwal, A. K. (2025) · Nature Communications · doi:10.1038/s41467-025-60484-z · Cited by 4
Harnessing the cooperation between DNA‐PK and cGAS in cancer therapies
Taffoni, C., Schüssler, M., Vila, I. K., & Laguette, N. (2023) · BioEssays · doi:10.1002/bies.202300045 · Cited by 4
A clinically-relevant STING agonist restrains human TH17 cell inflammatory profile
Damasceno, L. E. A., Cunha, T. M., Cunha, F. Q., Sparwasser, T. D., & Alves-Filho, J. C. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111007 · Cited by 4
How enzyme‐centered approaches are advancing research on cyclic oligo‐nucleotides
Wenzl, S. J., & Mann, C. C. D. O. (2024) · FEBS Letters · doi:10.1002/1873-3468.14838 · Cited by 4
Ritchie, C., Cordova, A. F., & Li, L. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/798397 · Cited by 4
Self-citationENPP1/CD203a-targeting heavy-chain antibody reveals cell-specific expression on human immune cells
Lorenz, H., Menzel, S., Roshchyna, N., Albrecht, B., Gebhardt, A. J., Schneider, E., Haag, F., Rissiek, B., Oheim, R., Koch‐Nolte, F., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05539-y · Cited by 3
Targeting pattern recognition receptors for cancer therapy: Mechanisms and strategies
Ouyang, D., Chen, R., Xie, H., Yang, X., Li, Q., & Chen, J. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.09.007 · Cited by 3
Rogers, L. M., Firestone, K., Chinni, R., Branco, A. C. C. C., Wrobleski, K. R., Chou, T., Goldstein, J. A., Gu, X., Mason, E. R., Chu, S., et al. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag051 · Cited by 3
Molecular mechanisms regulating cGAS/STING activation in health and disease
Cho, M.-G., Lee, R., Johnson, J., & Gupta, G. P. (2026) · Journal of Clinical Investigation · doi:10.1172/jci204548 · Cited by 4
Advances in structure-guided mechanisms impacting on the cGAS–STING innate immune pathway
Chen, K., Liao, J., Patel, D. J., & Xie, W. (2023) · Advances in immunology · doi:10.1016/bs.ai.2023.08.001 · Cited by 3
Herpes simplex virus-1 targets the 2′-3'cGAMP importer SLC19A1 as an antiviral countermeasure
Szemere, Z. K., Ijezie, E. C., & Murphy, E. A. (2024) · Virology · doi:10.1016/j.virol.2024.110320 · Cited by 3
Progress in extracellular vesicle@STING towards immune regulation
Wang, X., Lei, I. M., Li, B., & Dai, Y. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.110990 · Cited by 4
The Rab18/Ras/ERK/FosB/MMP3 Signaling Pathway Mediates Cell Migration Regulation by 2′3′-cGAMP
Deng, Y., Yuan, R., & Liu, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125758 · Cited by 3
Huang, P., Pistono, P. E., Martin, H. S., Fetzer, J. L., & Francis, M. B. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.5c00125 · Cited by 5
Onyedibe, K. I., Mohallem, R., Wang, M., Aryal, U. K., & Sintim, H. O. (2023) · Journal of Proteomics · doi:10.1016/j.jprot.2023.104869 · Cited by 3
A carrier for cyclic dinucleotides
Guey, B., & Ablasser, A. (2019) · Nature Immunology · doi:10.1038/s41590-019-0521-z · Cited by 5
Phagosome-mediated activation of STING during diverse bacterial infectionsPreprint
Ragland, S. A., & Kagan, J. C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.28.514268 · Cited by 3
Ritchie, C., & Li, L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.15.537029 · Cited by 3
Self-citationToxicity of extracellular cGAMP and its analogs to T cells is due to SLC7A1-mediated importPreprint
Sudaryo, V., Carvalho, D. R., Lee, J. M., Carozza, J. A., Cao, X., Cordova, A. F., & Li, L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.21.614248 · Cited by 3
Self-citationThe efficient synthesis and purification of 2′3’- cGAMP from Escherichia coli
Kulkarni, R. S., Maranholkar, V. M., Nguyen, N., Cirino, P. C., Willson, R. C., & Varadarajan, N. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1345617 · Cited by 3
Liu, M., Wang, M., Dai, H., Jiang, H., Liu, W., Cui, X., Tang, X., Zhao, Q., Hu, Y., Zhang, N., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119180 · Cited by 2
Kang, Y.-F., Chen, J.-M., Xu, B.-C., Xu, J.-N., Qin, Q., Wu, H.-L., Wang, J., Wang, R.-K., Wu, Y.-R., Tang, W., et al. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02636-3 · Cited by 2
Cilia, K., Gauci, Z., Agius, R., Fava, S., & Pace, N. P. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s604828 · Cited by 2
Al-Adayleh, T. Y. M., Ahmad, W., Rahiman, S. S. F., Murugaiyah, V., Mohamed, R., Afzal, S., Al-Ramamneh, R. S., & Attiq, A. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116832 · Cited by 3
Elmanfi, S., Onyedibe, K. I., Aryal, U. K., Könönen, E., Sintim, H. O., & Gürsoy, U. K. (2024) · Journal of Oral Microbiology · doi:10.1080/20002297.2024.2431453 · Cited by 2
Delivery strategies for cancer vaccines and immunoadjuvants
Graham-Gurysh, E. G., Carpenter, B. W., Beck, W. A., Varma, D. M., Vincent, B. G., Bachelder, E. M., & Ainslie, K. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85781-9.00014-2 · Cited by 2
Sandoval, P., Chuang, B.-C., Fallon, J. K., Smith, P. C., Chowdhury, S. K., Griffin, R., Xia, C. Q., Iwasaki, S., & Chothe, P. P. (2022) · The AAPS Journal · doi:10.1208/s12248-022-00745-7 · Cited by 2
Probing pathophysiology of extracellular cGAMP with substrate-selective ENPP1Preprint
Carozza, J. A., Cordova, A. F., AlSaif, Y., Böhnert, V., Skariah, G. M., & Li, L. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.04.442665 · Cited by 2
Self-citationABCC1/MRP1 exports cGAMP and modulates cGAS-dependent immunityPreprint
Maltbaek, J. H., Snyder, J. M., & Stetson, D. B. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.03.470980 · Cited by 2
ESCRT-dependent STING degradation curtails steady-state and cGAMP-induced signalingPreprint
Gentili, M., Liu, B., Papanastasiou, M., Dele-Oni, D. O., Schwartz, M. A., Carlson, R. J., Al’Khafaji, A. M., Krug, K., Brown, A., Doench, J. G., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.22.509044 · Cited by 2
A protective cGAMP-mediated anti-tumor immune response can proceed without LRRC8/VRAC channels
Thöne, F. M. B., Polovitskaya, M. M., Höpken, U. E., Rehm, A., & Jentsch, T. J. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.111060 · Cited by 1
Protective and pathogenic: The Janus-faced role of cGAS–STING in the brain
Corona, C., Kanzlemar, C., Hussaini, S. A., & Ratan, R. R. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261427904 · Cited by 1
Extracellular cGAMP in health and disease
Dai, Z., Ma, C., Ding, H., Fu, L., Jiang, H., & Tai, S. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00464-x · Cited by 1
Ragland, S. A., Lindblad, K. E., Li, Y., Choi, J. H., Okin, D. A., Mao, J. Q., Richmond-Buccola, D., Coronado, D. R., Brown, M. R., Snapper, S. B., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.06.023 · Cited by 1
Wang, M., Li, J., Wang, X., Chai, X., Luo, J., Zhang, Y., Chang, X., Sun, Y., & Wang, H. (2026) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2026.101537 · Cited by 2
Circadian Clock and Uptake Transporters
Lu, D., Chen, M., Wang, Y., Chen, M., & Wu, B. (2020) · Springer eBooks · doi:10.1007/978-981-15-8807-5_7 · Cited by 1
An anion channel for cyclic dinucleotides in T cells
Chu, J., & Qiu, Z. (2022) · Nature Immunology · doi:10.1038/s41590-021-01118-6 · Cited by 1
Pathophysiological functions of self-derived DNA
Ori, D., & Kawai, T. (2022) · International Reviews of Immunology · doi:10.1080/08830185.2022.2070616 · Cited by 1
Delivery strategies for STING agonists
Sun, X., Hay, I., Doran, P., Basireddy, S., Scott, M., Wu, Y., Al‐Dossary, A. A., & Li, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85781-9.00013-0 · Cited by 1
Methotrexate inhibition of muropeptide transporter SLC46A2 controls psoriatic skin inflammationPreprint
Bharadwaj, R., Lusi, C. F., Mashayekh, S., Nagar, A., Subbarao, M., Kane, G. I., Wodzanowski, K. A., Brown, A., Okuda, K., Monahan, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.29.509906 · Cited by 1
Gürler, G., Belder, N., Beker, M. Ç., Sever, M., Uruk, G., Kılıç, E., & Yemişçi, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.14.511731 · Cited by 1
Wang, Z., Ma, D., & Xi, Z. (2022) · Wiley eBooks · doi:10.1002/9781119692799.ch2 · Cited by 1
Propagation of neuronal micronuclei regulates microglial statesPreprint
Yano, S., Asami, N., Kishi, Y., Kubotani, H., Hattori, Y., Kitazawa, A., Hayashi, K., Kubo, K., Saeki, M., Maeda, C., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.31.551211 · Cited by 1
Smarduch, S., Moreno-Velásquez, S. D., Dadsena, S., Ilic, D., Morant, R., Pereira, G., Binder, M., García-Sáez, A., & Acebrón, S. P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.10.598238 · Cited by 1
Priya, R., Ye, M., Raghunandanan, S., Liu, Q., Li, W., Yu, Q., Lou, Y., Sintim, H. O., & Yang, X. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.13.607721 · Cited by 1
Johnson, R. M., Wang, S., Carozza, J. A., Fernández, D., Scicinski, J. J., Verity, N. A., Mardjuki, R. E., Cao, X., Papkoff, J. S., Ray, N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.18.654655 · Cited by 1
Self-citationMechanisms of Clearance of MHC I-deficient Tumors Induced by STING Agonists
Nicolai, C. J. (2020) · eScholarship (California Digital Library)
Metadata
- Authors
- Ritchie, C., Cordova, A. F., Hess, G. T., Bassik, M. C., & Li, L.
- Affiliations
- Stanford University (US)
- Stanford Medicine (US)
- Corresponding author
- Li, Lingyin
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 75
- Issue
- 2
- Pages
- 372-381.e5
- ISSN
- 1097-2765 (ISSN-L)
- PMC
- PMC6711396
- OpenAlex
- W2952481556
- Cited by
- 333
- References
- 44
- Citations by year
- 2026: 35 · 2025: 38 · 2024: 49 · 2023: 55 · 2022: 53 · 2021: 46 · 2020: 47 · 2019: 10
- FWCI
- 15.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5R00CA19089, DP2HD084069, DP2CA228044, 2T32GM007365, 5T32GM007276)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phosphodiesterase function and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Keywords
- SLC19A1, cGAMP, STING pathway, STING agonist, cancer immunotherapy, membrane transport, antitumor immunity
- MeSH terms
- STING Protein, Cell Membrane, Humans, Immunity, Innate, Membrane Proteins, Neoplasms, Nucleotides, Cyclic, Signal Transduction, Genome, Human, Cell Line, Tumor, Reduced Folate Carrier Protein, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review